CRU Hungary KFT (Site 0209)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Closed trials

• Completed

  Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)

  NCT03829332· Phase 3· Merck Sharp & Dohme LLC· Source